[1] GHOJAZADEH M,MOBASSERI M,MOSTAFAEI H,et al.The Global trends of thyroid cancer research:A scientometric study[J].Journal of Cancer Epidemiology,2024,2024:5747618.
[2] YAN KL,LI SP,TSENG CH,et al.Rising incidence and incidence-based mortality of thyroid cancer in california,2000-2017[J].The Journal of Clinical Endocrinology and Metabolism,2020,105(6):dgaa121.
[3] ABDULLAH MI,JUNIT SM,NG KL,et al.Papillary thyroid cancer:Genetic alterations and molecular biomarker investigations[J].International Journal of Medical Sciences,2019,16(3):450-460.
[4] MEGWALU UC, MOON PK.Thyroid cancer incidence and mortality trends in the United States:2000-2018[J].Official Journal of the American Thyroid Association,2022,325:560-570.
[5] PONGSAPICH W,CHONGKOLWATANA C,POUNGVARIN N,et al.BRAF mutation in cytologically indeterminate thyroid nodules:after reclassification of a variant thyroid carcinoma[J].Onco Targets and Therapy,2019,12:1465-1473.
[6] LI XJ,MAO XD,CHEN GF,et al.High BRAF V600E mutation frequency in Chinese patients with papillary thyroid carcinoma increases diag nostic efficacy in cytologically indeterminate thyroid nodules[J].Medicine(Baltimore),2019,98(28):e16343.
[7] 胡加银,陈潇,何霖,等.超声引导下细针抽吸细胞学检查联合BRAF~(V600E)基因检测诊断甲状腺微小乳头状癌的价值 [J].临床超声医学杂志,2022,24(02):151-154.
HU JY,CHEN X,HE L,et al.The value of ultrasound-guided fine needle aspiration cytology combined with BRAF~(V600E) gene detection in the diagnosis of papillary thyroid carcinoma [J].Journal of Clinical Ultrasound Medicine,2022,24(02):151-154.
[8]MAKBOUL R,MOSTAFA NM,EL-DEEK HEM,et al.Do BRAF V600E mutation and sodiumiodide symporter expression affect the response to radioactive iodine therapy in patients with papillary thyroid carcinoma[J].Nucl Med Commun,2020,41(5):416-425.
[9] XUE S,ZHANG L,WANG P,et al.Predictive factors of recurrence for multifocal papillary thyroid microcarcinoma with Braf(v600e) mutation:A single center study of 1,207 Chinese patients[J].Front Endocrinol(Lausanne),2019,10:407-409.
[10] BYCHKOV A.Prevalence of BRAF V600E mutation in Asian patients with thyroid cancer[J].Malays J Pathol,2017,39(1):95-96.
[11]GURSOY CA,UZUN C,KUL M,et al.The impact of arterial phase on the detection of cervical lymph node metastasis from papillary thyroid carcinoma:A quantitative evaluation on multiphasic computed tomography[J].Journal of Computer Assisted Tomography,2020,442:262-268.
[12] COHEN K,ELLIS M,KHOURY S,et al.Thyroid hormone is a MAPK-dependent growth factor for human myeloma cells acting via αvβ3 integrin[J].Molecular Cancer Research,2011,910:1385-1394.
[13] SHIRLEY LA,MCCARTY S,YANG MC,et al.Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic target[J].Surgery,2016,159(1):163-170.
[14]DAI DL,MAKRETSOV N,CAMPOS EI,et al.Increased expression of integrin-linked kinase is correlated with melanoma progression and poor patie nt survival[J].Clin Cancer Res,2003,9(12):4409-4414.
[15]YUAN D,ZHAO Y,WANG Y,et al.Effect of integrin linked kinase gene silencing on microRNA expression in ovarian cancer[J].Mol Med Rep,2017,16(5):7267-7276.
[16]WU PA,XIE LL,ZHAO DY,et al.Integrin-linked kinase is overexpressed in laryngeal squamous cell carcinoma and correlates with tumor proliferation,migration and invasion[J].Eur Rev Med Pharmacol Sci,2018,22(24):8740-8748.
[17]白东.EMT相关标记分子和ILK在结直肠癌组织中的表达相关性及其与患者癌细胞侵袭转移CT征象的关系[J].中国医疗器械信息,2018,24(04):11-12.
BAI D.The correlation between the expression of EMT related marker molecules and ILK in colorectal cancer tissues and their relationship with CT features of cancer cell invasion and metastasis in patients[J].China Medical Device Information,2018,24(04):11-12.
[18]徐丹,许海周.胆囊癌组织中β-catenin和ILK的表达及其与临床病理参数的相关性研究[J].河北医学,2018,24(11):1790-1793.
XU D,XU HZ.The expression of β-catenin and ILK in gallbladder cancer tissue and their correlate-on with clinical pathological parameters[J].Hebei Medical,2018,24(11):1790-1793.
[19]杨萌萌.中药夏枯草对BRAF突变型甲状腺乳头状癌恶性生物学行为的影响[D].郑州:河南中医药大学,2020.
YANG MM.The effect of Chinese herbal medicine prunella vulgaris on the malignant biological behavior of BRAF mutant papillary thyroid carcinoma[D].Zhengzhou:Henan University of Traditional Chinese Medicine,2020.